Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2016. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3298449013 | Oral form bicalutamide | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3298584014 | Oral form bicalutamide (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3488502011 | Product containing bicalutamide in oral dosage form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3497482010 | Bicalutamide in oral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3497483017 | Product containing bicalutamide in oral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3708812017 | Product containing bicalutamide in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3708813010 | Bicalutamide-containing product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing bicalutamide in oral dose form (medicinal product form) | Is a | Product containing bicalutamide | true | Inferred relationship | Existential restriction modifier | ||
| Product containing bicalutamide in oral dose form (medicinal product form) | Is a | Product manufactured as oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing bicalutamide in oral dose form (medicinal product form) | Has active ingredient | Bicalutamide | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing bicalutamide in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing bicalutamide in oral dose form (medicinal product form) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely bicalutamide 50 milligram/1 each conventional release oral tablet | Is a | False | Product containing bicalutamide in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet | Is a | False | Product containing bicalutamide in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing only bicalutamide in oral dose form (medicinal product form) | Is a | True | Product containing bicalutamide in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR